Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
CD22-directed CAR-T cells induce complete remissions in high-risk follicular and Mantle Cell Lymphoma with limited neurotoxicity
CD22-directed CAR-T cells induce complete remissions in high-risk follicular and Mantle Cell Lymphoma with limited neurotoxicity Srinagesh, H., Kramer, A., Hamilton, M., Su, Y., Kozy, K., Jackson, L., Brown, A., Denoble, K., Mavroukakis, S., Lohman, C., Cunanan, K., Agarwal, N., Bharadwaj, S., Reynolds, W., Arai, S., Johnston, L., Lowsky, R., Meyer, E., Negrin, R., Rezvani, A., Shizuru, J., Mikkilineni, L., Hosoya, H., Shiraz, L., Sidana, S., Weng, W., Kennedy, V., Smith, M., Dahiya, S., Davis, H., Ramakrishna, S., Schultz, L., Tunuguntla, R., Muffly, L., Mackall, C., Miklos, D., Frank, M. ELSEVIER. 2025: 4159-4160View details for DOI 10.1182/blood-2025-4159
View details for Web of Science ID 001663517100009